The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $424,351 in first-year total cost, median $212,176.
Most frequent study sections
- Development - 2 Study Section[DEV2]1
- Genomics, Computational Biology and Technology Study Section[GCAT]1
Most frequent institutions
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- TEXAS A&M UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | SINE-mediated Regulation of mRNA Epitranscriptome for Pluripotency Maintenance and Differentiation1R21HD106263-01A1 | HUANG, XIN | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $246,750 | DEV2 |
| 2019 | CLAP-seq: An Aptamer-Based Platform for Transcriptome-Wide Mapping of RNA Modifications1R21HD099707-01 | SCZEPANSKI, JONATHAN THOMAS | TEXAS A&M UNIVERSITY, TX | $177,601 | GCAT |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.